Results 111 to 120 of about 8,067 (198)

Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators [PDF]

open access: yes, 2014
Resurgent sodium currents contribute to the regeneration of action potentials and enhanced neuronal excitability. Tetrodotoxin-sensitive (TTX-S) resurgent currents have been described in many different neuron populations, including cerebellar and dorsal ...
Cummins, Theodore R.   +7 more
core   +3 more sources

ERK2 alone drives inflammatory pain but cooperates with ERK1 in sensory neuron survival [PDF]

open access: yes, 2015
Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are highly homologous yet distinct components of signal transduction pathways known to regulate cell survival and function.
Alter, Benedict J   +11 more
core   +2 more sources

Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms

open access: yesMolecular Metabolism, 2018
Objectives: G protein-coupled receptors (GPCRs) act as transmembrane molecular sensors of neurotransmitters, hormones, nutrients, and metabolites. Because unmyelinated vagal afferents richly innervate the gastrointestinal mucosa, gut-derived molecules ...
Kristoffer L. Egerod   +7 more
doaj   +1 more source

A small lipidated peptide targeting NaV1.8 channels attenuates osteoarthritic pain behavior and prevents bone erosion

open access: yesOsteoarthritis and Cartilage Open
Objective: In clinical practice, intra-articular therapies are commonly used for the management of osteoarthritis (OA) pain. However, these current treatments for OA-related pain are recognized for compromising joint integrity over time.
Raider Rodriguez, Arin Bhattacharjee
doaj   +1 more source

Pharmacological Frontiers: The Rise of Selective NaV1.8 Inhibition for Pain Management

open access: yesCNS Drugs
Pain is a multifaceted disorder encompassing sensory, emotional, and cognitive dimensions. It presents a ubiquitous challenge to human health and well-being, demanding effective and safe management strategies [1]. Various pharmacological interventions, including nonsteroidal anti-inflammatory drugs, antidepressants, anticonvulsants, and opioids, have ...
openaire   +3 more sources

Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

open access: yesPain and Therapy
Introduction There is a high unmet need for safe and effective non-opioid medicines to treat moderate to severe pain without risk of addiction. Voltage-gated sodium channel 1.8 (NaV1.8) is a genetically and pharmacologically validated pain target that is
Jeremiah D. Osteen   +8 more
doaj   +1 more source

Suzetrigine mechanism, efficacy, and clinical implications: A narrative review

open access: yesMediterranean Journal of Pharmacy and Pharmaceutical Sciences
Acute pain, especially in postoperative and trauma areas, continues to be a substantial clinical problem all around the world, and this has been made worse by the opioid crisis as well as the drawbacks of the current non-opioid analgesics.
Abduelmula R. Abduelkarem
doaj   +1 more source

Antihyperalgesic effects of ProTx-II, a Nav1.7 antagonist, and A803467, a Nav1.8 antagonist, in diabetic mice

open access: yesJournal of Experimental Pharmacology, 2015
Ken-ichiro Tanaka,1,2, Shota Sekino,1 Megumi Ikegami,1 Hiroko Ikeda,1 Junzo Kamei11Department of Pathophysiology and Therapeutics, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo, Japan; 2Department of Endocrinology and Metabolism,
Tanaka KI   +4 more
doaj  

Home - About - Disclaimer - Privacy